Divisions of Pediatric Surgery, The Montreal Children's Hospital, Montreal, QC, Canada.
J Pediatr Surg. 2013 May;48(5):924-9. doi: 10.1016/j.jpedsurg.2013.02.009.
Little is known about liveborn CDH patients who die without surgery. We audited a national CDH cohort to determine whether these patients were different from patients who received CDH repair.
A national CDH database was analyzed (2005-2009). After excluding infants with severe physiologic instability and genetic/congenital malformations, a potential surgical candidate (PSC) subgroup was identified. PSCs were compared to the operative group (OG) and the operative non-survivor (ONS) subgroup. Standard statistical analyses were performed.
Of 275 liveborns, 35 (13%) died without surgery. The PSC subgroup (n=11) had a median survival of 10 days (range: 3-18). Ten of 11 PSC infants were treated in ECMO centers, with 4 receiving ECMO. No differences in BW, GA, and rates of minor malformation were observed between PSC and OG patients. While neonatal illness severity (SNAP-II) predicted overall mortality, SNAP-II scores were similar between PSC and ONS groups (34 vs. 29; p=0.431). Furthermore, greater than 80% of infants with SNAP-II scores between 30 and 39 survived in the OG cohort.
Our analysis demonstrated that PSCs were similar to infants offered surgery based on illness severity and the presence of congenital malformations. We suggest that criteria for surgical ineligibility be developed to standardize the selection of surgical candidates.
对于未经手术治疗就死亡的活产先天性膈疝(CDH)患者,我们知之甚少。本研究审核了一个全国性的 CDH 队列,以确定这些患者与接受 CDH 修复的患者是否存在差异。
分析了一个全国性的 CDH 数据库(2005-2009 年)。在排除严重生理不稳定和遗传/先天性畸形的婴儿后,确定了一个潜在手术候选者(PSC)亚组。将 PSC 亚组与手术组(OG)和手术幸存者(ONS)亚组进行比较。进行了标准的统计分析。
在 275 例活产儿中,有 35 例(13%)未经手术死亡。PSC 亚组(n=11)的中位生存时间为 10 天(范围:3-18 天)。11 例 PSC 婴儿中有 10 例在 ECMO 中心接受治疗,其中 4 例接受 ECMO。PSC 和 OG 患者的 BW、GA 和轻微畸形发生率无差异。虽然新生儿疾病严重程度评分(SNAP-II)预测总体死亡率,但 PSC 和 ONS 组之间的 SNAP-II 评分相似(34 与 29;p=0.431)。此外,OG 队列中 SNAP-II 评分在 30 至 39 分之间的婴儿中,超过 80%存活。
我们的分析表明,基于疾病严重程度和先天性畸形的存在,PSC 与接受手术的婴儿相似。我们建议制定手术不合格标准,以规范手术候选者的选择。